
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.
AQEMIA is a fast-growing, next-gen pharma company focused on developing novel drug candidates for critical diseases. They are seeking a Staff AI Research Scientist to lead the development of AI algorithms for protein-ligand interactions and integrate innovative solutions into their Drug Discovery Platform. The role involves collaboration with researchers, computational chemists, and experts to maximize the impact of AI innovations.
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.